MongoCat.com

Myxedema coma

OVERVIEW

What is myxedema coma?

Myxedema coma is a life-threatening condition caused by severe hypothyroidism, characterized by decreased mental status, abnormally low body temperature, and multi-organ dysfunction affecting the cardiovascular, pulmonary, and other systems.

Is myxedema coma common?

Extremely rare.

SYMPTOMS

What are the common manifestations of myxedema coma?

The common manifestations of this condition include the following 6 aspects:

How dangerous is myxedema coma?

This condition can lead to organ failure in critical organs such as the heart, lungs, and brain, and may also trigger electrolyte imbalances. The mortality rate can be as high as 30%–40%.

CAUSES

What are the common causes of myxedema coma?

The primary cause of this condition is long-term, severe, and untreated hypothyroidism.

Additionally, certain external factors may trigger the onset of this disease in hypothyroid patients, such as infections, myocardial infarction, exposure to cold, trauma, surgery, or certain medications (sedatives, amiodarone, etc.).

Who is more susceptible to myxedema coma?

Older women are more prone to developing this condition.

DIAGNOSIS

What tests are needed when myxedema coma is suspected?

Thyroid function tests, thyroid autoantibodies, complete blood count, blood glucose, blood electrolytes, blood cortisol and adrenocorticotropic hormone, blood gas analysis, electrocardiogram, thyroid ultrasound, cardiac ultrasound, cranial CT or MRI.

Why are these tests performed for patients with myxedema coma? What is their purpose?

What diseases can myxedema coma be easily confused with?

This condition is often mistaken for adrenal insufficiency, anterior pituitary hypofunction, acute cerebral infarction or hemorrhage, and hypoglycemic coma. The above tests help doctors differentiate between these conditions.

TREATMENT

Which department should I visit for myxedema coma?

Due to the severity of the condition, patients often initially seek treatment in the emergency department or ICU. Follow-up care can be provided by endocrinologists or general physicians.

How is myxedema coma treated?

How should patients with myxedema coma be cared for?

Do myxedema coma patients require long-term medication?

Yes.

Patients often have severe, permanent hypothyroidism and require lifelong levothyroxine therapy. Discontinuation may trigger a recurrence of myxedema coma.

What should be noted when taking oral levothyroxine for myxedema coma?

Levothyroxine is taken once daily, preferably on an empty stomach in the morning, 0.5–1 hour before breakfast, as some foods may interfere with absorption.

If morning dosing is impractical, it can be taken at bedtime, at least 4 hours after dinner.

Other medications should be taken at least 4 hours apart, as some (e.g., aluminum hydroxide, calcium carbonate, cholestyramine, sucralfate, ferrous sulfate, fiber supplements) may affect absorption or metabolism.

Certain drugs (e.g., phenobarbital, phenytoin, carbamazepine, rifampin, isoniazid, lovastatin, amiodarone, sertraline, chloroquine) may accelerate levothyroxine clearance, necessitating dose adjustments.

Always inform your doctor of concurrent medications to determine proper dosing and timing.

Is follow-up required after discharge for myxedema coma?

Yes. During hospitalization, thyroid function, electrolytes, cortisol, and blood counts are monitored, with medication adjustments as needed.

After discharge, thyroid function should be checked every 4–6 weeks until treatment goals are met.

Once stabilized, monitor thyroid function every 4–6 months. Patients with adrenal insufficiency require biannual checks for cortisol, electrolytes, and blood pressure.

Can myxedema coma be cured?

With prompt treatment, myxedema coma can be resolved, but the underlying hypothyroidism is usually permanent, requiring lifelong levothyroxine.

Recurrence is possible if triggering factors reappear.

DIET & LIFESTYLE

What should patients who have experienced myxedema coma pay attention to in their daily lives?

Take medication on time and attend follow-up examinations; do not stop or reduce dosage without medical guidance.

Most myxedema coma patients are elderly, who may forget medications and experience declining self-care abilities.

Family members should provide close monitoring. Seek immediate medical attention if symptoms like severe cold intolerance, fatigue, drowsiness, edema, constipation, weight gain, or mental confusion/lethargy occur.

PREVENTION

Can Myxedema Coma Be Prevented?

Some patients with myxedema coma may not be aware that they have severe hypothyroidism, especially the elderly. If family members pay more attention to the elderly and promptly seek medical attention when they notice unusual symptoms, some dangerous situations can be avoided.

For patients already diagnosed with hypothyroidism, there are measures to prevent myxedema coma, including: